Pressreleases, rapporter och nyheter för Curasight
Press release from Companies: Annual Report for the fiscal year 2020
Press release from Companies: Year-end report October – December 2020
Press release from Companies: US patent application 14/399,820 relating to uTREAT[®] is accepted for grant
Press release from Companies: Results from Phase II study in prostate cancer to be published in the Journal of Nuclear Medicine
Press release from Companies: Results from Phase II study in prostate cancer to be published in the Journal of Nuclear Medicine
Press release from Companies: Japanese patent application 2019-005811 is accepted for grant
Press release from Companies: Financial Calendar 2021
Press release from Companies: Interim report January – September 2020
Press release from Companies: Interim report January – September 2020
Press release from Companies: Interim report January – September 2020
Press release from Companies: Curasight initiates pre-clinical study on therapy (uTREAT[®]) in brain cancer and signs CRO-agreement
Press release from Companies: Canadian patent application relating to uTRACE[®] is ready for allowance in Canada
